Histopathological classification of Pseudomyxoma Peritonei and the prognostic importance of PINCH protein

Anticancer Research

Volumn 32, Issue 4, 2012, Pages 1443-1448

  Andréasson, Håkan ^a   Wanders, Alkwin ^a   Sun, Xiao Feng ^b   Willén, Roger ^a   Graf, Wilhelm ^a   Nygren, Peter ^a   Glimelius, Bengt ^a,c   Zhang, Zhi Yong ^d   Mahteme, Haile ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d TANGSHAN GONGREN HOSPITAL   (China)

Author keywords

Cytokeratin 7; Histopathology; Ki 67; PINCH; Protein expression; Pseudomyxoma peritonei

Indexed keywords

FLUOROURACIL; FOLINATE CALCIUM; LIM HOMEODOMAIN PROTEIN; MITOMYCIN C; PARTICULARLY INTERESTING NEW CYSTEINE HISTIDINE PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR CLASSIFICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; FEMALE; HUMANS; LIM DOMAIN PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PSEUDOMYXOMA PERITONEI;

EID: 84859942945     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smeenk RM, van Velthuysen MLF, Verwaal VJ and Zoetmulder FAN: Appendiceal neoplasms and pseudomyxoma peritonei: A population-based study. Eur J Surg Ocol 34: 196-201, 2008.
2. Sugarbaker PH: Pseudomyxoma peritonei: a cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 279: 109-111, 1994.
3. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92: 85-91, 2001. (Pubitemid 32623044)
4. Young R, Gilks C and Scully R: Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Pathol 15: 415-429, 1991.
5. Szych C, Staebler A, Connolly D, Wu R, Cho K and Ronnett B: Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 154: 1849-1855, 1999. (Pubitemid 29262868)
6. Sugarbaker PH and Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 8: 727-731, 1999. (Pubitemid 30013648)
7. Chua TC, Liauw W, SaxenaA, Al-Mohaimeed K, Fransi S, Zhao J and Morris DL: Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy. Am J Surg 2: 149-156, 2011.
8. Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD and Moran B: Operative findings, early complications and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal orgin. Dis Colon Rectum 3: 293-299, 2011.
9. Bradley RF, Stewart JH, Russell GB, Levine EA and Geisinger KR: Pseudomyxoma peritonei of appendiceal origin: a clinicopathological analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 5: 551-559, 2006. (Pubitemid 44265007)
10. Rearden A: A new LIM protein containing an autoepitope homologous to senescent cell antigen. Biochem Biophys Res Commun 201: 1124-1131, 1994.
11. Wang-Rodriquez J, Dreilinger AD, Alsharabi GM and Rearden A: The signaling adapter protein PINCH is upregulated in the stroma of common cancers, notably at invasion edges. Cancer 95: 1387-1395, 2002. (Pubitemid 35013075)
12. Gao J, Arbman G, Rearden A and Sun X-F: Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer. Neoplasia 6: 796-801, 2004. (Pubitemid 40041498)
13. Harmon RL and Sugarbaker PH: Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2: 3-13, 2005.
14. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F and Zoetmulder FAN: Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88: 458-463, 2001. (Pubitemid 32238713)
15. Sobin LH and Wittekind C: TNM Classification of Malignant Tumors 6thed. New York: Wiley-Liss, Inc., 2002.
16. Mahteme H, Hansson J, Berglund Å, Pahlman L, Glimelius B, Nygren P and Graf W: Improved survival in patients with peritoneal metastases from colorectal cancer. A preliminary study. Br J Cancer 90: 403-407, 2004. (Pubitemid 38250636)
17. Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, Beaujard AC and Noel GF: Hyperthermic Intraperitoneal Chemotherapy: Nomenclature and Modalities of Perfusion. J Surg Oncol 98: 242-246, 2008.
18. Campana WM, Myers RR and Rearden A: Identification of PINCH in Schwann cells and DRG neurons: shutting and signaling after nerve injury. Glia 41: 213-223, 2003. (Pubitemid 36258467)